Delivery Order SPE2DB20D3103-SPE2DB26FL3U9
- Not listed
- The Defense Logistics Agency awarded a $3,457.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of September 30, 2025. This non-set-aside award was made on September 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, specifically...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $2,945.52 for Dexamethasone 20 mg/5 mL vials (5 mL quantity) on a firm fixed price basis. This award, issued on July 17, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for U.S. military...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a $2,466.91 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dexamethasone 20 mg/5 mL vials. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used in military and federal healthcare...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,824.44 on August 13, 2025, to supply Dexamethasone 10mg/ml in vials (25-count units) to the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 10, 2025. The delivery order represents work performed under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for the supply of Dexamethasone 20 mg/5 mL vials (5 mL unit size) under a firm fixed-price contract valued at $1,069.60. The award was competitively issued on May 30, 2025, with an ultimate completion date of June 2, 2025, and does not include a set-aside designation. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dexamethasone 20 mg/5 ml vials in 5 ml quantities, with a ceiling value of $1,046.46. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,188.80 firm fixed-price delivery order is for the supply of 4566401459 dexamethasone 10 mg/ml vials, with a completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a $1,242.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Dexamethasone 4 mg tablets in unit-dose packages of 100 units. This is a non-set-aside competitive award with an ultimate completion date of July 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL3U9Delivery Order
The Defense Logistics Agency awarded a $3,267.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials, with an ultimate completion date of October 27, 2025. This non-set-aside contract was competitively awarded on October 24, 2025, with performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The company's IDC with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dexamethasone, a corticosteroid with broad clinical applications in military and federal healthcare settings, represents the type of essential pharmaceutical commodity routinely procured through this prime vendor vehicle to ensure consistent availability of critical medications across the defense medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/24/25 |